ProfileGDS4718 / 1553175_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 23% 23% 27% 27% 28% 23% 23% 28% 27% 31% 19% 19% 42% 31% 23% 16% 25% 18% 23% 28% 25% 25% 19% 22% 27% 22% 16% 33% 20% 28% 25% 24% 33% 31% 30% 27% 23% 26% 24% 42% 29% 25% 24% 26% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.2609223
GSM549102patient 115, normal, homogenized [OPG study]4.2766923
GSM549104patient 119, normal, homogenized [OPG study]4.4125727
GSM549108patient 138, normal, homogenized [OPG study]4.479127
GSM549119patient 077, normal, homogenized [OPG study]4.4616628
GSM549133patient 032, cancer, homogenized [OPG study]4.1920823
GSM549139patient 042, cancer, homogenized [OPG study]4.2396723
GSM549099patient 107, normal, homogenized [OPG study]4.4880628
GSM549109patient 139, normal, homogenized [OPG study]4.4307827
GSM549110patient 046, normal, homogenized [OPG study]4.5652931
GSM549114patient 063, normal, homogenized [OPG study]4.0620819
GSM549122patient 082, normal, homogenized [OPG study]4.1108419
GSM549134patient 033, cancer, homogenized [OPG study]5.0877842
GSM549136patient 036, cancer, homogenized [OPG study]4.5148231
GSM549140patient 044, cancer, homogenized [OPG study]4.2312623
GSM549111patient 047, normal, homogenized [OPG study]3.9678116
GSM549113patient 057, normal, homogenized [OPG study]4.2872725
GSM549132patient 031, cancer, homogenized [OPG study]4.0715718
GSM549137patient 038, cancer, homogenized [OPG study]4.2287823
GSM549142patient 047, cancer, homogenized [OPG study]4.5826928
GSM549100patient 110, normal, homogenized [OPG study]4.3651325
GSM549107patient 135, normal, homogenized [OPG study]4.2927825
GSM549115patient 068, normal, homogenized [OPG study]4.0421619
GSM549116patient 072, normal, homogenized [OPG study]4.205122
GSM549120patient 078, normal, homogenized [OPG study]4.434927
GSM549131patient 030, cancer, homogenized [OPG study]4.1634322
GSM549118patient 074, normal, homogenized [OPG study]4.0187116
GSM549129patient 027, cancer, homogenized [OPG study]4.6710433
GSM549123patient 088, normal, homogenized [OPG study]4.139920
GSM549124patient 006, cancer, homogenized [OPG study]4.5015928
GSM549126patient 015, cancer, homogenized [OPG study]4.3426425
GSM549128patient 025, cancer, homogenized [OPG study]4.2798824
GSM549103patient 117, normal, homogenized [OPG study]4.7370533
GSM549117patient 073, normal, homogenized [OPG study]4.5523831
GSM549138patient 041, cancer, homogenized [OPG study]4.5014530
GSM549141patient 045, cancer, homogenized [OPG study]4.3538127
GSM549130patient 028, cancer, homogenized [OPG study]4.2662223
GSM549101patient 111, normal, homogenized [OPG study]4.3765226
GSM549105patient 128, normal, homogenized [OPG study]4.3285324
GSM549106patient 134, normal, homogenized [OPG study]5.0347842
GSM549112patient 048, normal, homogenized [OPG study]4.4749229
GSM549125patient 011, cancer, homogenized [OPG study]4.3642525
GSM549127patient 024, cancer, homogenized [OPG study]4.2898524
GSM549135patient 035, cancer, homogenized [OPG study]4.3172926